Guidance
7 Related NICE guidance
Details are correct at the time of publication. Further information is available on the NICE website.
Published
-
Aflibercept solution for injection for treating wet age\u2011\related macular degeneration. NICE technology appraisal guidance 294 (2013).
-
Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion. NICE technology appraisal guidance 283 (2013).
-
Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237) . NICE technology appraisal guidance 274 (2013).
-
Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion. NICE technology appraisal guidance 229 (2011).
-
Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87 (2009).
-
Ranibizumab and pegaptanib for the treatment of age\u2011\related macular degeneration. NICE technology appraisal guidance 155 (2008).
-
Type 1 diabetes. NICE clinical guideline 15 (2004).